AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
I take issue with the article concerning the estrogen-only arm of the Women's Health Initiative ("WHI Quantifies Risks, Benefits of Estrogen Therapy," May 1, 2004, p. 1).
It almost seems as if there is an anti-estrogen movement afoot whose agenda is to discount the benefits of estrogen, distorting or manipulating any data to achieve its goal. The interpretation of the most recent WHI findings is a perfect example of this. When the first arm of the WHI study showed a barely significant increase in breast cancer of 8 cases per 10,000 women, this finding was blasted across all the media.
When the second arm showed a decrease in breast cancer of 7 cases per 10,000 women, I did not see one news report, magazine article, or editorial. If any other medication had been shown to decrease breast cancer by 23%, there would have been a national education campaign to get the good news out to the public.
The statements by Dr. Stephen Hulley and ...
Source: HighBeam Research, WHI's 'anti-estrogen agenda'.(Letters)(Letter to the Editor)